I'm not buying *for* either of those things, I consider them to be value add, I'm buying for their current plans of CFP within 12 months and existing product lines. The cancer diagnostics is a cherry on top.
Ann: Half Year Results Presentation - 30 June 2022, page-10
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.74M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 13.0¢ | $4.992K | 38.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 538697 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 38461 | 1 |
View Market Depth
| Last trade - 10.09am 18/09/2024 (20 minute delay) ? |
| UBI (ASX) Chart |